United States · FDA National Drug Code directory
MYHIBBIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24338-018_d90d3f5a-98a2-4e50-8bb1-db76875c9b8c
- Product NDC
- 24338-018
- Form
- SUSPENSION
- Composition / generic term
- MYCOPHENOLATE MOFETIL
- Labeler
- Azurity Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240610
- Source listing expiry
- 20271231
Source-listed ingredients
- MYCOPHENOLATE MOFETIL — 200 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (24338-018-01) / 175 mL in 1 BOTTLE, PLASTIC · 24338-018-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →